β-strand mimicking macrocyclic amino acids:: Templates for protease inhibitors with antiviral activity

被引:62
作者
Glenn, MP
Pattenden, LK
Reid, RC
Tyssen, DP
Tyndall, JDA
Birch, CJ
Fairlie, DP
机构
[1] Victorian Infect Dis Reference Lab, Carlton, Vic 3053, Australia
[2] Univ Queensland, Inst Mol Biosci, Ctr Drug Design & Dev, Brisbane, Qld 4072, Australia
关键词
D O I
10.1021/jm010414i
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
New amino acids are reported in which component macrocycles are constrained to mimic tripeptides locked in a beta-strand conformation. The novel amino acids involve macrocycles functionalized with both an N- and a C-terminus enabling addition of appendages at either end to modify receptor affinity, selectivity, or membrane permeability. We show that the cycles herein are effective templates within inhibitors of HIV-1 protease. Eleven compounds originating from such bifunctionalized cyclic templates are potent inhibitors of HIV-1 protease (Ki 0.3-50 nM; pH 6.5, I = 0.1 M). Unlike normal peptides comprising amino acids, five of these macrocycle-containing compounds are potent antiviral agents with sub-micromolar potencies (IC50 170-900 nM) against HIV-1 replication in human MT2 cells. The most active antiviral agents are the most lipophilic, with calculated values of LogD(6.5) greater than or equal to 4. All molecules have a conformationally constrained 17-membered macrocyclic ring that has been shown to structurally mimic a tripeptide segment (Xaa)-(Val/Ile)-(Phe/Tyr) of a peptide substrate in the extended conformation. The presence of two trans amide bonds and a para-substituted aromatic ring prevents intramolecular hydrogen bonds and fixes the macrocycle in the extended conformation. Similarly constrained macrocycles may be useful templates for the creation of inhibitors for the many other proteins and proteases that recognize peptide beta-strands.
引用
收藏
页码:371 / 381
页数:11
相关论文
共 37 条
[1]   REGIOSELECTIVE STRUCTURAL AND FUNCTIONAL MIMICRY OF PEPTIDES - DESIGN OF HYDROLYTICALLY-STABLE CYCLIC PEPTIDOMIMETIC INHIBITORS OF HIV-1 PROTEASE [J].
ABBENANTE, G ;
MARCH, DR ;
BERGMAN, DA ;
HUNT, PA ;
GARNHAM, B ;
DANCER, RJ ;
MARTIN, JL ;
FAIRLIE, DP .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1995, 117 (41) :10220-10226
[2]   Structure-activity relationships for macrocyclic peptidomimetic inhibitors of HIV-1 protease. [J].
Abbenante, G ;
Bergman, DA ;
Brinkworth, RI ;
March, DR ;
Reid, RC ;
Hunt, PA ;
James, IW ;
Dancer, RJ ;
Garnham, B ;
Stoermer, ML ;
Fairlie, DP .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (21) :2531-2536
[3]  
Accelrys Inc, 2001, INS 2 MOD ENV REL 20
[4]   Collagen cross-links: Synthesis of pyridinoline, deoxypyridinoline and their analogues [J].
Adamczyk, M ;
Johnson, DD ;
Reddy, RE .
TETRAHEDRON, 1999, 55 (01) :63-88
[5]  
[Anonymous], 1996, MOL MODELLING PRINCI
[6]   Molecular recognition of protein-ligand complexes: Applications to drug design [J].
Babine, RE ;
Bender, SL .
CHEMICAL REVIEWS, 1997, 97 (05) :1359-1472
[7]   KINETIC-PROPERTIES OF HIV-1 PROTEASE PRODUCED BY TOTAL CHEMICAL SYNTHESIS WITH CYSTEINE RESIDUES REPLACED BY ISOSTERIC L-ALPHA-AMINO-N-BUTYRIC ACID [J].
BERGMAN, DA ;
ALEWOOD, D ;
ALEWOOD, PF ;
ANDREWS, JL ;
BRINKWORTH, RI ;
ENGLEBRETSEN, DR ;
KENT, SBH .
LETTERS IN PEPTIDE SCIENCE, 1995, 2 (02) :99-107
[8]  
*COMP CHEM LTD, CALC US PALLAS PROL
[9]   IN-VIVO EMERGENCE OF HIV-1 VARIANTS RESISTANT TO MULTIPLE PROTEASE INHIBITORS [J].
CONDRA, JH ;
SCHLEIF, WA ;
BLAHY, OM ;
GABRYELSKI, LJ ;
GRAHAM, DJ ;
QUINTERO, JC ;
RHODES, A ;
ROBBINS, HL ;
ROTH, E ;
SHIVAPRAKASH, M ;
TITUS, D ;
YANG, T ;
TEPPLER, H ;
SQUIRES, KE ;
DEUTSCH, PJ ;
EMINI, EA .
NATURE, 1995, 374 (6522) :569-571
[10]  
Darke P L, 1994, Adv Pharmacol, V25, P399, DOI 10.1016/S1054-3589(08)60438-X